Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia

Author： Martelli Alberto M Evangelisti Camilla Chiarini Francesca Grimaldi Cecilia Manzoli Lucia McCubrey James A

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.18, Iss.9, 2009-09, pp. : 1333-1349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies

By Barrett David Brown Valerie I. Grupp Stephan A. Teachey David T.

Pediatric Drugs, Vol. 14, Iss. 5, 2012-10 ,pp. : 299-316

Adis International

Access to resources Recommend Favorite

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 36-62

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead

Current Medicinal Chemistry, Vol. 20, Iss. 24, 2013-08 ,pp. : 2991-3010

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-03 ,pp. : 36-62

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 188-204

Bentham Science Publishers

Access to resources Recommend Favorite